Featured on Scrip: AbCellera finds antibody candidates other technologies might not

AbCellera is discovering and developing more next-generation therapeutic antibodies with its core technology that integrates proprietary immunizations, microfluidics, high-throughput imaging, genomics, deep computation, artificial intelligence and laboratory automation. By combining its core technology with Celium™, the world’s first data mining and antibody visualization software, AbCellera’s platform can search and analyze natural immune systems 10x faster and 100x deeper than other technologies to deliver exponentially more antibodies against any disease.


Read full coverage on Scrip Informa Pharma Intelligence.


Together we can make game-changing discoveries.